Viewing Study NCT06710132

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:45 PM
Ignite Modification Date: 2026-01-29 @ 6:19 AM
Study NCT ID: NCT06710132
Status: RECRUITING
Last Update Posted: 2025-12-19
First Post: 2024-11-22
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
Sponsor: EMD Serono Research & Development Institute, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
None Gastric Cancer View
None Non-Small Cell Lung Cancer (NSCLC) View
None Pancreatic Cancer View
None Pancreatic Ductal Adenocarcinoma (PDAC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ADC View
None TOP1 inhibitor View
None Gastric Cancer View
None Gastroesophageal junction cancer View
None Non-Small Cell Lung Cancer View
None Pancreatic Cancer View
None Solid Tumors View